ClinicalTrials.gg
Drug

Teduglutide clinical trials

Also written Gattex, TAK-633, Revestive and ALX-0600.

studies test it
35
open now
1
in phase 3
20
first study started
2003

How each study uses teduglutide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the teduglutide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Dec 2012 · GATTEX KIT · NDA 203441 (FDA, Drugs@FDA)
European Union
30 Aug 2012 · Revestive · EMEA/H/C/002345 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Teduglutide
29
Teduglutide 0.05 mg/kg/d
2
Teduglutide (ALX-0600)
2

Brand

Gattex
13
Revestive
2

Development codes

TAK-633
3
ALX-0600
2

Studies by the year they started

35 studies that test it; most in 2018 (5)

Studies that test teduglutide, by start year
YearStudies
20031
20042
20051
20061
20071
20081
20093
20101
20121
20131
20142
20151
20162
20174
20185
20192
20201
20211
20222
20241
20251

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
6
Phase 2
8
Phase 3
20
Phase 4
2
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 24 · Other 11

Shire (19) · Takeda (3) · University Health Network, Toronto (3) · Nycomed (2) · Assistance Publique - Hôpitaux de Paris (1) · University of Freiburg (1) · Massachusetts General Hospital (1) · Daniel Dante Yeh (1)

Often tested with

Tested in the same studies.

Acetylglucosamine (1) · Budesonide (1) · Omega-N-Methylarginine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test teduglutide, phase 3 first.

Studies

Open first, then newest update. How each study uses teduglutide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 35

See all 35 studies that test teduglutide →

Codes

What other systems call teduglutide · ClinicalTrials.gg INT004730

  • MeSH (NLM) C494910teduglutideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7M19191IKGTEDUGLUTIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 1364468Confirmed FDA, Wikidata
  • Wikidata Q7694156teduglutideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66582TeduglutideConfirmed FDA, Wikidata
  • DrugBank DB08900One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.